Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03975491 · ClinicalTrials.gov registry record · NA
The Exercise And Colorectal Cancer Treatment Trial
A NA study of Colon Cancer and Rectal Cancer, sponsored by Pennington Biomedical Research Center.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03975491: Active NA study of Colon Cancer and Rectal Cancer, sponsored by Pennington Biomedical Research Center.
NCT03975491 is a NA study of Colon Cancer and Rectal Cancer that is active but no longer recruiting, run by Pennington Biomedical Research Center. The registered enrollment target is 60 participants, below the 4,456-participant average among 97 other Colon Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03975491, a NA study of Colon Cancer and Rectal Cancer, is active but no longer recruiting, sponsored by Pennington Biomedical Research Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the biologic processes through which exercise may prevent disease recurrence in patients who have completed treatment for colorectal cancer.
Conditions Studied
Interventions
- BEHAVIORAL Wait-List Control
- BEHAVIORAL Moderate-Intensity Aerobic Exercise
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2026-01-01 |
| Phase | NA |
What the registry record for NCT03975491 still lists
NCT03975491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 4,456-participant average among 97 other Colon Cancer trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Colon Cancer appearing as the primary indexed condition, and to 2 interventions - of which Wait-List Control is the first listed.
NCT03975491 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT03975491 about?
NCT03975491 is a clinical study titled "The Exercise And Colorectal Cancer Treatment Trial". This study will examine the biologic processes through which exercise may prevent disease recurrence in patients who have completed treatment for colorectal cancer.
What is the current status of trial NCT03975491?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2019-08-01. Estimated completion is 2026-01-01.
What conditions does trial NCT03975491 study?
This clinical trial studies the following conditions: Colon Cancer, Rectal Cancer.
What interventions are being tested in trial NCT03975491?
The interventions under investigation include: Wait-List Control (BEHAVIORAL), Moderate-Intensity Aerobic Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03975491?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03975491 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03975491's enrollment target sits among peer trials
60 60th of 97 higher than 35 of 97 other Colon Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colon Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Resilience and Equity in Aging, Cancer, and Health (REACH)
RECRUITING · NA
-
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
RECRUITING · NA
-
PrehabPal: A Digital Tool to Help Older Adults Prepare for Cancer Surgery
RECRUITING · NA
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI